Cancer therapy–related hypertension: a scientific statement from the american heart association
Contemporary anticancer drugs have significantly improved cancer survival at the expense
of cardiovascular toxicities, including heart disease, thromboembolic disease, and …
of cardiovascular toxicities, including heart disease, thromboembolic disease, and …
Associations of rotational shift work and night shift status with hypertension: a systematic review and meta-analysis
S Manohar, C Thongprayoon… - Journal of …, 2017 - journals.lww.com
Background: The reported risks of hypertension (HTN) in rotating shift and night shift workers
are controversial. The objective of this meta-analysis was to assess the association between …
are controversial. The objective of this meta-analysis was to assess the association between …
Hypertension and prohypertensive antineoplastic therapies in cancer patients
DCH Van Dorst, SJH Dobbin, KB Neves… - Circulation …, 2021 - Am Heart Assoc
The development of a wide range of novel antineoplastic therapies has improved the
prognosis for patients with a wide range of malignancies, which has increased the number …
prognosis for patients with a wide range of malignancies, which has increased the number …
[HTML][HTML] Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease
Background Senescent cells, which can release factors that cause inflammation and
dysfunction, the senescence-associated secretory phenotype (SASP), accumulate with …
dysfunction, the senescence-associated secretory phenotype (SASP), accumulate with …
[HTML][HTML] Acute kidney injury in patients treated with immune checkpoint inhibitors
Background Immune checkpoint inhibitor-associated acute kidney injury (ICPi-AKI) has
emerged as an important toxicity among patients with cancer. Methods We collected data on …
emerged as an important toxicity among patients with cancer. Methods We collected data on …
Clinical features and outcomes of immune checkpoint inhibitor–associated AKI: a multicenter study
FB Cortazar, ZA Kibbelaar, IG Glezerman… - Journal of the …, 2020 - journals.lww.com
Background Despite increasing recognition of the importance of immune checkpoint
inhibitor–associated AKI, data on this complication of immunotherapy are sparse. Methods …
inhibitor–associated AKI, data on this complication of immunotherapy are sparse. Methods …
Programmed cell death protein 1 inhibitor treatment is associated with acute kidney injury and hypocalcemia: meta-analysis
S Manohar, P Kompotiatis… - Nephrology Dialysis …, 2019 - academic.oup.com
Background The aim of this meta-analysis was to assess the risks and incidence of
nephrotoxicity and electrolyte abnormalities in patients receiving programmed cell death …
nephrotoxicity and electrolyte abnormalities in patients receiving programmed cell death …
A mitochondrial permeability transition pore inhibitor improves renal outcomes after revascularization in experimental atherosclerotic renal artery stenosis
Revascularization improves blood pressure but not renal function in most patients with
atherosclerotic renal artery stenosis (ARAS), possibly related to injury incurred during renal …
atherosclerotic renal artery stenosis (ARAS), possibly related to injury incurred during renal …
[HTML][HTML] Immune checkpoint inhibitors and immune-related adverse renal events
SM Herrmann, MA Perazella - Kidney international reports, 2020 - Elsevier
Renal toxicities have been increasingly recognized as complications of the immune
checkpoint inhibitors (ICIs). Recent studies have outlined the incidence and potential risk …
checkpoint inhibitors (ICIs). Recent studies have outlined the incidence and potential risk …
Corrigendum to 'Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney …
Corrigendum to ‘Senolytics decrease senescent cells in humans: Preliminary report from a
clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease’ EBioMedicine …
clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease’ EBioMedicine …